Cargando…

SARS-CoV-2 Variants in Lebanon: Evolution and Current Situation

SIMPLE SUMMARY: Thanks to whole genome sequencing approaches, the proteins that compose the SARS-CoV-2 virus that causes COVID-19 are compared, and mutations and differences highlighted. This allows strains to be classified into clades or lineages, according to marker mutations in their proteins as...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fayad, Nancy, Abi Habib, Walid, Kandeil, Ahmed, El-Shesheny, Rabeh, Kamel, Mina Nabil, Mourad, Youmna, Mokhbat, Jacques, Kayali, Ghazi, Goldstein, Jimi, Abdallah, Jad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8232177/ https://www.ncbi.nlm.nih.gov/pubmed/34198622 http://dx.doi.org/10.3390/biology10060531

Ejemplares similares

Lebanese SARS-CoV-2 genomics: 24 months of the pandemic
por: Fayad, Nancy, et al.
Publicado: (2022)

Detection of Coronaviruses in Bats in Lebanon during 2020
por: Kandeil, Ahmed, et al.
Publicado: (2023)

Prevalence and determinants of SARS-CoV-2 neutralizing antibodies in Lebanon
por: Bahlawan, Omar, et al.
Publicado: (2022)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Surveillance for Coronaviruses in Bats, Lebanon and Egypt, 2013–2015
por: Shehata, Mahmoud M., et al.
Publicado: (2016)

Complete Genome Sequence of Middle East Respiratory Syndrome Coronavirus Isolated from a Dromedary Camel in Egypt
por: Kandeil, Ahmed, et al.
Publicado: (2016)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
por: Moatasim, Yassmin, et al.
Publicado: (2023)

Incidence and seroprevalence of seasonal influenza a viruses in Egypt: Results of a community‐based cohort study
por: Gomaa, Mokhtar R., et al.
Publicado: (2022)

Induced humoral immunity of different types of vaccines against most common variants of SARS-CoV-2 in Egypt prior to Omicron outbreak
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

Insights into Genetic Characteristics and Virological Features of Endemic Avian Influenza A (H9N2) Viruses in Egypt from 2017–2021
por: El Sayes, Mohamed, et al.
Publicado: (2022)

The Epidemiological and Molecular Aspects of Influenza H5N1 Viruses at the Human-Animal Interface in Egypt
por: Kayali, Ghazi, et al.
Publicado: (2011)

A Recombinant Influenza A/H1N1 Carrying A Short Immunogenic Peptide of MERS-CoV as Bivalent Vaccine in BALB/c Mice
por: Shehata, Mahmoud M., et al.
Publicado: (2019)

Complete Genome Sequence of the First H5N1 Avian Influenza Virus Isolated from Chickens in Lebanon in 2016
por: Ibrahim, Elias, et al.
Publicado: (2016)

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
por: El-Shesheny, Rabeh, et al.
Publicado: (2022)

PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Comparative Virological and Pathogenic Characteristics of Avian Influenza H5N8 Viruses Detected in Wild Birds and Domestic Poultry in Egypt during the Winter of 2016/2017
por: Moatasim, Yassmin, et al.
Publicado: (2019)

Surveillance for avian influenza viruses in wild birds at live bird markets, Egypt, 2014‐2016
por: Kayed, Ahmed S., et al.
Publicado: (2019)

COVID-19 infection and seroconversion rates in healthcare workers in Lebanon: An observational study
por: Helou, Mariana, et al.
Publicado: (2023)

Evolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015
por: Mahmoud, Sara Hussein, et al.
Publicado: (2019)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
por: Kutkat, Omnia, et al.
Publicado: (2022)

Avian Influenza A(H5N1) Virus in Egypt
por: Kayali, Ghazi, et al.
Publicado: (2016)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021
por: Kandeil, Ahmed, et al.
Publicado: (2022)

Common childhood vaccines do not elicit a cross-reactive antibody response against SARS-CoV-2
por: Kandeil, Ahmed, et al.
Publicado: (2020)

Beirut Explosion Effects on COVID-19 Situation in Lebanon
por: Hashim, Hashim Talib, et al.
Publicado: (2021)

Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
por: Moatasim, Yassmin, et al.
Publicado: (2021)

We are underestimating, again, the true burden of H5N1 in humans
por: Gomaa, Mokhtar, et al.
Publicado: (2023)

Living Day by Day: The Meaning of Living With HIV/AIDS Among Women in Lebanon
por: Kaplan, Rachel L., et al.
Publicado: (2016)

Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study
por: Abo Shama, Noura M., et al.
Publicado: (2022)

Comparative pathogenic potential of avian influenza H7N3 viruses isolated from wild birds in Egypt and their sensitivity to commercial antiviral drugs
por: Kayed, Ahmed E., et al.
Publicado: (2023)

Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
por: Kandeel, Amr, et al.
Publicado: (2023)

Continuing Threat of Influenza (H5N1) Virus Circulation in Egypt
por: Kayali, Ghazi, et al.
Publicado: (2011)

Situation analysis of community pharmacy owners in Lebanon
por: Hallit, Souheil, et al.
Publicado: (2017)

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2
por: Mostafa, Ahmed, et al.
Publicado: (2020)

Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
por: Roshdy, Wael H., et al.
Publicado: (2022)

Incidence, household transmission, and neutralizing antibody seroprevalence of Coronavirus Disease 2019 in Egypt: Results of a community-based cohort
por: Gomaa, Mokhtar R., et al.
Publicado: (2021)

Pharmaceutical brochures in Lebanon: do they meet WHO recommendations?
por: Fadoul, Yara, et al.
Publicado: (2022)

The impact of the Beirut blast on the COVID-19 situation in Lebanon
por: Fares, Mohamad Y., et al.
Publicado: (2021)

Antibiotic Stewardship in Disaster Situations: Lessons Learned in Lebanon
por: Shallal, Anita, et al.
Publicado: (2022)

Determinants of having severe acute respiratory syndrome coronavirus 2 neutralizing antibodies in Egypt
por: El Rifay, Amira S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_nt7qg7dbgngn8h8beron89v95t